Growth Metrics

Armata Pharmaceuticals (ARMP) Net Margin (2016 - 2020)

Quarterly results put Net Margin at 15193.55% for Q2 2020, changed N/A from a year ago — trailing twelve months through Jun 2020 was 18229.91% (changed N/A YoY), and the annual figure for FY2017 was 12488.7%, down 315177.0%.

Armata Pharmaceuticals has reported Net Margin over the past 6 years, most recently at 15193.55% for Q2 2020.

  • Net Margin reached 15193.55% in Q2 2020 per ARMP's latest filing, down from 11650.0% in the prior quarter.
  • Across five years, Net Margin topped out at 2050.0% in Q3 2017 and bottomed at 43181.82% in Q4 2016.
  • Median Net Margin over the past 3 years was 11650.0% (2017), compared with a mean of 15010.05%.
  • The largest annual shift saw Net Margin plummeted -4069744bps in 2016 before it soared 3153182bps in 2017.
  • Over 3 years, Net Margin stood at 43181.82% in 2016, then soared by 73bps to 11650.0% in 2017, then plummeted by -30bps to 15193.55% in 2020.
  • Business Quant data shows Net Margin for ARMP at 15193.55% in Q2 2020, 11650.0% in Q4 2017, and 2050.0% in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 34.53%
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 20.17%
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 17.65%
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 -15,193.55%
Dec 31, 2017 -11,650.00%
Sep 30, 2017 -2,050.00%
Jun 30, 2017 -28,717.86%
Mar 31, 2017 -11,193.10%
Dec 31, 2016 -43,181.82%
Sep 30, 2016 -12,375.86%
Jun 30, 2016 -6,165.05%